Title 42, The Public Health and WelfareRelease 119-110

§285d–5 Arthritis and Musculoskeletal Diseases Demonstration Projects

Title 42 › CHAPTER 6A — PUBLIC HEALTH SERVICE › SUBCHAPTER III — NATIONAL RESEARCH INSTITUTES › Part C — Specific Provisions Respecting National Research Institutes › subpart 4 — national institute of arthritis and musculoskeletal and skin diseases › § 285d–5

Last updated Sep 22, 2026|Official source

Summary

The Director of the Institute can give grants to public and private nonprofit groups to set up and run projects that develop and show new ways to screen for, detect, and refer people for treatment of arthritis and musculoskeletal diseases. These projects must share what they learn with doctors and other health workers and must work with federal, state, local, and regional health agencies, with related centers funded under the law, and with the data system described below. Grants can support six kinds of programs: finding and diagnosing people early who are at risk; improving how hospitals and doctors refer patients to treatment centers; standardizing patient records; teaching health professionals about these methods; giving the public information about early detection, prompt care, following treatment plans, and warning against unapproved or ineffective tests, treatments, drugs, or devices; and studying how these diseases develop and spread, including social, environmental, behavior, nutrition, and genetic factors. The Director must also make sure patient data and recordkeeping are standardized for collecting, storing, analyzing, finding, and sharing information, working with the projects, the funded centers, and others involved.

Full Legal Text

Title 42, §285d–5

The Public Health and Welfare, Source: USLM XML via OLRC

(a)Grants for establishment and support

The Director of the Institute may make grants to public and private nonprofit entities to establish and support projects for the development and demonstration of methods for screening, detection, and referral for treatment of arthritis and musculoskeletal diseases and for the dissemination of information on such methods to the health and allied health professions. Activities under such projects shall be coordinated with Federal, State, local, and regional health agencies, centers assisted under section 285d–6 of this title, and the data system established under subsection (c).

(b)Programs included

Projects supported under this section shall include—

(1)programs which emphasize the development and demonstration of new and improved methods of screening and early detection, referral for treatment, and diagnosis of individuals with a risk of developing arthritis and musculoskeletal diseases;

(2)programs which emphasize the development and demonstration of new and improved methods for patient referral from local hospitals and physicians to appropriate centers for early diagnosis and treatment;

(3)programs which emphasize the development and demonstration of new and improved means of standardizing patient data and recordkeeping;

(4)programs which emphasize the development and demonstration of new and improved methods of dissemination of knowledge about the programs, methods, and means referred to in paragraphs (1), (2), and (3) of this subsection to health and allied health professionals;

(5)programs which emphasize the development and demonstration of new and improved methods for the dissemination to the general public of information—

(A)on the importance of early detection of arthritis and musculoskeletal diseases, of seeking prompt treatment, and of following an appropriate regimen; and

(B)to discourage the promotion and use of unapproved and ineffective diagnostic, preventive treatment, and control methods for arthritis and unapproved and ineffective drugs and devices for arthritis and musculoskeletal diseases; and

(6)projects for investigation into the epidemiology of all forms and aspects of arthritis and musculoskeletal diseases, including investigations into the social, environmental, behavioral, nutritional, and genetic determinants and influences involved in the epidemiology of arthritis and musculoskeletal diseases.

(c)Standardization of patient data and recordkeeping

The Director shall provide for the standardization of patient data and recordkeeping for the collection, storage, analysis, retrieval, and dissemination of such data in cooperation with projects assisted under this section, centers assisted under section 285d–6 of this title, and other persons engaged in arthritis and musculoskeletal disease programs.

Reference

Citations & Metadata

Citation

42 U.S.C. § 285d–5

Title 42, The Public Health and Welfare

Last Updated

Sep 22, 2026

Release point: 119-110